Bafna Pharmaceuticals Limited (BOM:532989)
400.55
+7.85 (2.00%)
At close: Oct 6, 2026
Bafna Pharmaceuticals Company Description
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India.
The company offers its products in various dosage forms, including tablets, capsules, and solid orals.
It provides various products for cardiovascular and hypertension, potent oncology, anti-infectives, central nervous system, and diabetic related diseases, as well as provision of contract research and manufacturing services.
It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, and Nigeria.
Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. The company operates as a subsidiary of SRJR Lifesciences LLP.
Bafna Pharmaceuticals Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 339 |
| CEO | Bansilal Mahaveer Bafna |
Contact Details
Address: Bafna Towers Chennai, Tamil Nadu 600001 India | |
| Phone | 91 44 2526 7517 |
| Website | bafnapharma.com |
Stock Details
| Ticker Symbol | 532989 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bansilal Mahaveer Bafna | Chief Executive Officer |
| Melagiri Sridhar | Chief Financial Officer |